- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Nuance strikes deal to acquire Dictaphone for $357 million
Voice recognition software developer Nuance has cut a deal to acquire Dictaphone. Nuance executives say they expect the all-cash $357 million agreement to accelerate the adoption of voice recognition as a replacement for manual transcription.
Voice recognition software developer Nuance has cut a deal to acquire Dictaphone. Nuance executives say they expect the all-cash $357 million agreement to accelerate the adoption of voice recognition as a replacement for manual transcription.
"It is our goal by the end of this decade to replace most manual transcription in healthcare with speech-enabled automated solutions, giving care providers and medical transcription services the ability to reduce manual transcription costs by over $5 billion a year," said Paul Ricci, chairman and CEO of Nuance.
U.S. medical providers spend about $10 billion annually to transcribe spoken reports, according to Ricci.
The deal to merge Dictaphone and Nuance is expected to close March 31, pending regulatory approvals and due diligence. If it does, Dictaphone will operate as a wholly owned subsidiary of Nuance.
Editor's Note: What the merger will mean for Nuance, Dictaphone, and the medical community at large will be featured in the Feb. 20 issue of SCAN.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
